Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow

Cytometry Part B - Clinical Cytometry

Volumn 70, Issue 6, 2006, Pages 391-399

  Jones, Elena A ^a   English, Anne ^a   Kinsey, Sally E ^b   Straszynski, Liz ^a   Emery, Paul ^a   Ponchel, Frederique ^a   McGonagle, Dennis ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c CALDERDALE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Bone marrow stromal cells; Mesenchymal stem cells; Multipotent mesenchymal stromal cells; Phenotype

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CD45 ANTIGEN; ENDOGLIN; GLYCOPHORIN A; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR RECEPTOR; PROTEIN SH2; PROTEIN SH3;

ACCURACY; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL ISOLATION; CELL SELECTION; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; EVALUATION; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYME CELL; MULTIPOTENT STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STROMA CELL; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MIDDLE AGED; MULTIPOTENT STEM CELLS; SENSITIVITY AND SPECIFICITY; STROMAL CELLS;

EID: 33750478692     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20118     Document Type: Article

References (30)

1. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A; the International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395.
2. Friedenstein AJ, Chalakhyan RK, Latsinik NV, Panasyuk AF, Keiless-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Transplantation 1974;17:331-340.
3. Barry FP, Murphy JM. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 2004;36:568-584.
4. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9-20.
5. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
6. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289-301.
7. Deschaseaux F, Charbord P. Human marrow Stromal precursors are α1- integrin subunit-positive. J Cell Physiol 2000;184:319-325.
8. Majumdar MK, Banks V, Peluso DP, Morris EA. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 2000;185:98-106.
9. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
10. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002;30:783-791.
11. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002;46:3349-3360.
12. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified Stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-1835.
13. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003;18:696-704.
14. Stewart K, Monk P, Walsh S, Jefferiss CM, Letchford J, Beresford JN. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: A comparative investigation in vitro. Cell Tissue Res 2003;313:281-290.
15. Deschaseaux F, Gindraux F, Saadi R, Obert L, Chalmers D, Herve P. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br J Haematol 2003;122:506-517.
16. Campioni D, Lanza F, Moretti S, Dominici M, Punturieri M, Pauli S, Hofmann T, Horwitz E, Castoldi GL. Functional and immunophenotypic characteristics of isolated CD105(+) and fibroblast(-) stromal cells from AML: Implications for their plasticity along endothelial lineage. Cytotherapy 2003;5:66-79.
17. Tondreau T, Lagneaux L, Dejeneffe M, Delforge A, Massy M, Mortier C, Bron D. Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: Phenotype, proliferation kinetics and differentiation potential. Cytotherapy 2004;6:372-379.
18. Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Guerin JJ, Pigeon P, Descamps S, Boisgard S, Berger MG. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 2005;33:219-225.
19. Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in humans: Anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-1738.
20. Simmons PJ, Masinovsky U, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992;80:388-395.
21. Westen H, Bainton DF. Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors. J Exp Med 1979;150:919-937.
22. Blazsek I, Liu XH, Anjo A, Quittet P, Comisso M, Kim-Triana B, Misset JL. The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones. Exp Hematol 1995;23:309-319.
23. Duhrsen U, Hossfeld DK. Stromal abnormalities in neoplastic bone marrow diseases. Ann Hematol 1996;73:53-70.
24. Wlodarski KH, Janowska-Wieczorek A. Precursor cells of fibroblast colony forming unit in the normal and pathologic human bone marrow and in the peripheral blood. Folia Haematol Int Mag Klin Morphol Blutforsch 1984;111:686-691.
25. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest 1995;95:264-271.
26. Banfi A, Bianchi G, Galotto M, Cancedda R, Quarto R. Bone marrow stromal damage after chemo/radiotherapy: Occurrence, consequences and possibilities of treatment. Leuk Lymphoma 2001;42:863-870.
27. Bianco P, Costantini M, Dearden LC, Bonucci E. Alkaline phosphatase positive precursors of adipocytes in the human bone marrow. Br J Haematol 1988;68:401-413.
28. Rossant J. Stem cells from the Mammalian blastocyst. Stem Cells 2001;19:477-482.
29. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci 2005;12:47-57.
30. Gregoretti MG, Gottardi D, Ghia P, Bergui L, Merico F, Marchisio PC, Caligaris-Cappio F. Characterization of bone marrow stromal cells from multiple myeloma. Leuk Res 1994;18:675-682.